| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4894b730bbf70303cda455bb8c651eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb5d56372e987504a646f7e4de2ea782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99dfdd02bcde8ca0dc96c2777083c0e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e5adf9f33e27c1a548b7b236e3a5a73 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1289 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 |
| filingDate |
2011-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3228c5367f9fcc3ffe67437a00ec659e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ddd1e4344b04693bb631e946884751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3a8496cc3b6aacce7026df7f89b62d8 |
| publicationDate |
2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013142800-A1 |
| titleOfInvention |
Mycobacterial Antigen Composition |
| abstract |
There is provided an antigenic composition comprising (a) a first mycobacterial antigenic polypeptide or a first mycobacterial polynucleotide; and (b) a second mycobacterial antigenic polypeptide or a second mycobacterial polynucleotide; wherein: (i) said first mycobacterial antigenic polypeptide comprises a polypeptide sequence having at least 70% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 1 or 7, or a fragment thereof having at least 7 consecutive amino acids thereof; (ii) said first mycobacterial polynucleotide comprises a polynucleotide sequence encoding said first mycobacterial antigenic polypeptide; (iii) said second mycobacterial antigenic polypeptide comprises a polypeptide sequence having at least 70% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 5, or a fragment thereof having at least 7 consecutive amino acids thereof; and (iv) said second mycobacterial polynucleotide comprises a polynucleotide sequence encoding said second mycobacterial polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787842-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11014969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10428122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015165014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4176897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11692014-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357555-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016529223-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014210018-A1 |
| priorityDate |
2010-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |